Loading company…
RetroSense Therapeutics develops gene therapies intended to restore functional vision in people with blindness.
RetroSense Therapeutics develops gene therapeutics for blindness caused by retinitis pigmentosa and advanced dry age-related macular degeneration. Founded in 2009, the company is based in Ann Arbor, US.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in